Browne L Daniel

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2019-03-19	2019-03-18	Revance Therapeutics Inc (RVNC)	PlS Planned sale	12,135 +1.5% 485.83 US$2,447,694	12,135 +1.5%	485.83	US$2,447,694
2019-02-20	2019-02-19	Revance Therapeutics Inc (RVNC)	PlS Planned sale	29,067 -22.8% 202.85 US$1,828,010	29,067 -22.8%	202.85	US$1,828,010